SOURCE: BIOLASE Technology, Inc.

BIOLASE Technology, Inc.

August 29, 2011 09:00 ET

BIOLASE Granted Canadian Approval to Sell Waterlase iPlus™ All-Tissue Dental Laser Systems

IRVINE, CA--(Marketwire - Aug 29, 2011) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser manufacturer and distributor, today announced that it has received approval from the Health Canada-Medical Device Bureau to sell its Waterlase iPlus™ all-tissue dental laser systems throughout Canada. Canada has an estimated 19,000 licensed dentists. BIOLASE sells its products in Canada through a direct sales force and selected distributors.

The Waterlase iPlus, with its Intuitive Power Control, not only addresses the key functional needs for the next generation of laser dentists, but it also delivers double the power and cutting speed with unparalleled control and versatility for all laser dentist users, from the beginner to the expert. Performing most types of procedures with the new Waterlase iPlus provides minimal to no pain or discomfort, minimizes the need for local anesthetic in most restorative cases, eliminates the risk of bacterial and viral cross-contamination associated with conventional drills and burs, and results in preserving the tissue biologically intact, and without causing the damaging micro-fractures of the tooth structure and avoiding the necrosis caused by heat and abrasion.

Chairman and CEO Federico Pignatelli commented, "Canada, 19,000 dentists strong, historically represented one of the most robust markets for BIOLASE and its products. Our brand is highly recognized for its innovation, and our installed base is large, loyal and committed. Today's approval to sell our new flagship product, the Waterlase iPlus, is an important milestone in spreading the reach of our cutting edge technology in a greater multitude of markets. The Canadian dental community is recognized as one of the world's most high tech prone and highly receptive to laser technology. As the dominant player in the field, we expect Canada to be a strong contributor to our growth and enduring success."

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at, Twitter at, and YouTube at

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:
    Jill Bertotti
    Allen & Caron